NCT05967299
Study of Intravenous ZMA001 in Healthy Subjects No drug interventions basic_science 1 recruiting NCT06454422
Implementing the Wuqinxi on Patients With Pulmonary Arterial Hypertension No drug interventions supportive_care Not Available not_yet_recruiting NCT06477640
Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension No drug interventions treatment Not Available recruiting NCT04084678
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH treatment 3 terminated NCT04796337
A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12) treatment 3 recruiting NCT06553937
Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg other 1 completed NCT06553924
Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg other 1 completed NCT03449524
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) treatment 2 terminated NCT03683186
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension treatment 3 enrolling_by_invitation NCT02276872
Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years No drug interventions treatment 2 completed NCT02149095
Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of TransCon PEG Treprostinil in Healthy Male Volunteers No drug interventions treatment 1 withdrawn NCT04309838
Observation Study With Implantable Medication Pump for Intravenous Treprostinil Therapy in Patients With Pulmonary Arterial Hypertension No drug interventions Not Available Not Available unknown_status NCT04053543
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension treatment 2 terminated NCT01092897
Pulmonary Hypertension and Imatinib No drug interventions Not Available Not Available completed NCT03626688
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients No drug interventions treatment 3 recruiting NCT01320865
Biomarkers in Pulmonary Arterial Hypertension Treated With Nilotinib No drug interventions Not Available Not Available withdrawn NCT03362047
(RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment) treatment 2 recruiting NCT01347216
COMPERA / COMPERA-KIDS No drug interventions Not Available Not Available recruiting NCT00586794
Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients No drug interventions treatment 3 terminated NCT05947240
Effects of UE Aerobic Exercise on Exercise Capacity and PA in Patients With Pulmonary Arterial Hypertension. No drug interventions treatment Not Available completed NCT03523910
Right Ventricular Pulmonary Vascular Interaction in Pulmonary Hypertension No drug interventions diagnostic Not Available completed NCT03145298
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy No drug interventions treatment 1 completed NCT06493461
A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults No drug interventions treatment 1 not_yet_recruiting NCT05546125
a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China No drug interventions Not Available Not Available completed NCT03235401
The PAH Disability and Bothersomeness Questionnaire No drug interventions Not Available Not Available unknown_status NCT01800292
Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH. No drug interventions diagnostic 4 completed NCT04663217
Exercise Hemodynamic, Right Ventricular Coupling and Echocardiography in Pulmonary Hypertension No drug interventions Not Available Not Available completed NCT05029167
REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study) No drug interventions treatment Not Available unknown_status NCT06172790
The Effects of the Otago Exercise Program No drug interventions treatment Not Available not_yet_recruiting NCT03863990
Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs No drug interventions Not Available Not Available completed NCT04104490
Angiotensin Converting Enzyme (ACE2), Brain, Gut Dysbiosis in Pulmonary Hypertension No drug interventions Not Available Not Available completed NCT02631421
Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH No drug interventions Not Available Not Available completed NCT05566002
Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension No drug interventions Not Available Not Available recruiting NCT03928002
4DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease No drug interventions diagnostic Not Available unknown_status NCT00423202
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension. No drug interventions treatment 3 completed NCT04567602
A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag No drug interventions Not Available Not Available completed NCT03365479
Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension No drug interventions basic_science Not Available completed NCT00878943
Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study No drug interventions Not Available Not Available no_longer_available NCT04316143
Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH No drug interventions treatment 2 completed NCT02112487
Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH treatment 3 completed NCT01117987
Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) treatment 3 terminated NCT00617487
Pulmonary Arterial Hypertension in Systemic Sclerosis No drug interventions Not Available Not Available unknown_status NCT00705133
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension No drug interventions treatment 2 completed NCT05977933
Assessing the Utility of Submaximal CPET in Treatment Management of PAH No drug interventions Not Available Not Available not_yet_recruiting NCT00494533
Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension No drug interventions treatment 4 terminated NCT02371733
Aerobic Exercise Training in Pulmonary Arterial Hypertension No drug interventions supportive_care Not Available completed NCT01477333
Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® treatment 2 completed NCT02579954
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension No drug interventions treatment Not Available completed NCT00723554
Iloprost Power Disc-15 in Pulmonary Arterial Hypertension No drug interventions treatment 3 terminated NCT04991454
Xenon MRI Pulm Hypertension No drug interventions diagnostic 2 recruiting NCT04489251
Assessment of the TGF-beta Pathway and Micro-RNA in Pediatric Pulmonary Arterial Hypertension No drug interventions Not Available Not Available unknown_status NCT02734953
Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH treatment 2 completed NCT01572077
Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension No drug interventions basic_science Not Available completed NCT03492177
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension treatment 2 active_not_recruiting NCT02676947
A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension treatment 2 completed NCT01165047
Nitric Oxide, GeNO Nitrosyl Delivery System treatment 2 completed NCT05828147
Anti-CD20 Antibodies for Treatment of SLE-PAH treatment 4 recruiting NCT01934647
Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003) No drug interventions treatment 1 terminated NCT00814645
Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers No drug interventions treatment 1 completed NCT01319045
Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease treatment Not Available terminated NCT04273945
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension treatment 3 active_not_recruiting NCT03838445
Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH) No drug interventions treatment Not Available recruiting NCT01647945
FK506 (Tacrolimus) in Pulmonary Arterial Hypertension treatment 2 completed NCT02279745
Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension treatment 2 completed NCT02304198
Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH treatment 2 / 3 completed NCT01443598
Pulmonary Hypertension in Interstitial Lung Disease No drug interventions Not Available Not Available completed NCT03489005
Effect of BIA 5 1058 on Cardiac Repolarization treatment 1 completed NCT00593905
Pharmacogenomics in Pulmonary Arterial Hypertension No drug interventions Not Available Not Available withdrawn NCT06321705
Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension No drug interventions Not Available Not Available available NCT00617305
Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1) No drug interventions treatment 4 completed NCT05147805
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension treatment 2 recruiting NCT03954405
Multi-marker Approach for Risk Assessment in PAH No drug interventions Not Available Not Available recruiting NCT06317805
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients treatment 4 recruiting NCT04266197
Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study treatment 2 recruiting NCT01077297
Tezosentan in Pulmonary Arterial Hypertension treatment 2 terminated NCT04908397
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension No drug interventions other 1 completed NCT06104228
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) No drug interventions diagnostic 2 not_yet_recruiting NCT03057028
Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension treatment 1 completed NCT03795428
Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004 treatment 2 terminated NCT01447628
IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients treatment 2 completed NCT01433328
Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain treatment 4 terminated NCT01520493
Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial Hypertension No drug interventions diagnostic Not Available completed NCT04207593
The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia treatment 2 completed NCT01723371
Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children treatment 1 / 2 withdrawn NCT00964678
Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension treatment 1 / 2 completed NCT03187678
Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension treatment 3 completed NCT00705588
Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids. No drug interventions treatment 4 unknown_status NCT03197688
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States No drug interventions Not Available Not Available completed NCT00581607
Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension No drug interventions treatment 2 / 3 completed NCT01642407
Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension treatment 4 completed NCT02484807
Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH No drug interventions Not Available Not Available completed NCT03496207
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) treatment 2 completed NCT03078907
Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension. other 4 completed NCT05413109
COMPression of Left Main coRonary artEry in patientS With Pulmonary Arterial Hypertension aSymptomatIc fOr aNgina No drug interventions diagnostic Not Available recruiting NCT03889509
A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis No drug interventions Not Available Not Available completed NCT05179356
Dapagliflozin in Pulmonary Arterial Hypertension treatment 2 recruiting NCT04972656
Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension treatment Not Available recruiting NCT01365585
Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension Not Available Not Available completed NCT03648385
Effects of DHEA in Pulmonary Hypertension treatment 2 active_not_recruiting NCT01338415
FUTURE 3 Study Extension treatment 3 completed NCT03612115
Neuromuscular Electrical Stimulation in Pulmonary Arterial Hypertension No drug interventions treatment Not Available completed NCT02889315
LenusPro Pump in PAH Treated With Treprostinil No drug interventions Not Available Not Available unknown_status NCT03744637
A Study of Single Doses of MK -5475 on Pulmonary Vascular Resistance (MK-5475-002) No drug interventions treatment 1 completed NCT05818137
A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020) treatment 3 active_not_recruiting NCT01560637
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension treatment 3 completed NCT02284737
A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH treatment 4 terminated NCT04505137
A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers No drug interventions treatment 1 completed NCT06350032
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH treatment 3 recruiting NCT05947032
Supervised Endurance Training Among Pulmonary Arterial Hypertension Patients No drug interventions treatment Not Available completed NCT06481852
A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension No drug interventions supportive_care 1 not_yet_recruiting NCT01781052
Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients Not Available Not Available completed NCT01847352
Iron Status and Hypoxic Pulmonary Vascular Responses basic_science Not Available completed NCT02782052
Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension treatment 3 withdrawn NCT01223352
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension treatment 3 completed NCT03893500
Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test No drug interventions diagnostic Not Available active_not_recruiting NCT05587400
Consistency of Electrical Cardiometry and Pulmonary Artery Catheter diagnostic Not Available recruiting NCT04915300
Apabetalone for Pulmonary Arterial Hypertension treatment 2 not_yet_recruiting NCT05135000
Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension No drug interventions treatment 2 terminated NCT06582459
Efficacy and Safety of High-Flow Nasal Cannula Versus Noninvasive Ventilation for Pulmonary Arterial Hypertension-Associated Acute Respiratory Failure No drug interventions Not Available Not Available active_not_recruiting NCT00303459
Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) treatment 4 completed NCT04650659
Functional Exercise Tests in Patients With Systemic Sclerosis No drug interventions Not Available Not Available unknown_status NCT05968859
A Study of Pulmonary Hypertension Peripheral Limitations No drug interventions treatment Not Available recruiting NCT03344159
Spironolactone Therapy in Chronic Stable Right HF Trial treatment 4 completed NCT06476470
Taiwan Interstitial Lung Disease Multi-center Investigation and Registry No drug interventions Not Available Not Available recruiting NCT05679570
Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial) treatment 2 active_not_recruiting NCT05624242
Assessment of Right Ventricular Function by Cardiac MRI in Patients With Pulmonary Arterial Hypertension (IRMA) No drug interventions Not Available Not Available not_yet_recruiting NCT05557942
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) treatment 3 terminated NCT03229499
Pulmonary Hypertension and Anastrozole Trial treatment 2 completed NCT01389206
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Not Available Not Available completed NCT03166306
Angiogenic Imaging in Pulmonary Arterial Hypertension No drug interventions diagnostic 1 / 2 completed NCT02999906
Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension treatment 3 withdrawn NCT02074449
Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin) No drug interventions Not Available Not Available completed NCT00377949
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients No drug interventions Not Available Not Available completed NCT00609349
The Early Recognition of Pulmonary Arterial Hypertension No drug interventions screening Not Available completed NCT01798849
A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001) No drug interventions treatment 1 completed NCT01027949
An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension treatment 3 completed NCT01148836
Coenzyme Q-10 and Pulmonary Arterial Hypertension No drug interventions treatment Not Available completed NCT05521113
Home-based Pulmonary Rehabilitation With Remote Monitoring in Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT05767918
StratosPHere (Non-interventional Study) No drug interventions Not Available Not Available completed NCT05600218
RWD Patients With Pulmonary Arterial Hypertension Treated With IP Prostacyclin Receptor Agonists No drug interventions Not Available Not Available recruiting NCT06528418
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath No drug interventions Not Available Not Available recruiting NCT02845518
Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA) No drug interventions diagnostic Not Available recruiting NCT03782818
Olaparib for PAH: a Multicenter Clinical Trial treatment 1 / 2 recruiting NCT00452218
Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 1 completed NCT00554619
A Study to Evaluate GSK1325760A - a Long-Term Extension Study No drug interventions treatment 3 completed NCT04994119
Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics treatment 1 completed NCT00741819
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects No drug interventions treatment 4 completed NCT02800941
Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension Not Available Not Available completed NCT02234141
Selonsertib in Adults With Pulmonary Arterial Hypertension treatment 2 completed NCT05825417
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx treatment 4 recruiting NCT03105934
Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension No drug interventions health_services_research Not Available completed NCT01317134
Endothelial Function in Patients With Pulmonary Arterial Hypertension No drug interventions diagnostic Not Available completed NCT06384534
Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy in Pulmonary Vascular Disease (PVD) No drug interventions other Not Available not_yet_recruiting NCT04282434
DNA Methylation Dynamics Underlying Arterial Remodeling in PAH Patients: CLEOPAHTRA Clinical Trial No drug interventions Not Available Not Available completed NCT01560624
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy treatment 3 completed NCT06092424
High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA) No drug interventions supportive_care Not Available active_not_recruiting NCT00430716
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension. No drug interventions treatment 4 terminated NCT01494896
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching No drug interventions Not Available Not Available terminated NCT04053296
Long-term Outcomes of Pregnant Women With PAH No drug interventions Not Available Not Available unknown_status NCT02958358
FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan No drug interventions Not Available Not Available withdrawn NCT01042158
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis treatment 4 completed NCT03522935
Subcutaneous Elafin in Healthy Subjects treatment 1 completed NCT00989963
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) treatment 2 completed NCT02309463
Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial Hypertension No drug interventions Not Available Not Available withdrawn NCT01496963
Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia No drug interventions Not Available Not Available completed NCT00086463
Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 2 completed NCT05339386
Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension Not Available Not Available recruiting NCT00578786
A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202) No drug interventions treatment 3 completed NCT05039086
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - PDE5 Inhibitors vs Endothelin Receptor Antagonist No drug interventions Not Available Not Available completed NCT01153386
Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine treatment 1 completed NCT01649739
Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost treatment 4 unknown_status NCT01409122
Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects treatment 1 completed NCT05167825
A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension treatment 3 active_not_recruiting NCT03288025
Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE) No drug interventions treatment Not Available active_not_recruiting NCT04663230
Right Atrial Fibrosis in Pulmonary Hypertension No drug interventions Not Available Not Available completed NCT06429930
Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults No drug interventions treatment 1 not_yet_recruiting NCT04808830
Prevalence of Musculoskeletal Pain and Its Impact on Quality of Life and Functional Exercise Capacity in Patients With Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT06550648
Evaluation of the Role of Epstein-Bar Virus in Patients With Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT04813926
A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH) Not Available Not Available active_not_recruiting NCT05934526
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) treatment 3 recruiting NCT06405126
Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary Hypertension No drug interventions Not Available Not Available recruiting NCT01645826
Efficacy Study of Cardizem in Pulmonary Arterial Hypertension treatment Not Available withdrawn NCT00483626
Hemodynamic Response After Six Months of Sildenafil No drug interventions treatment 4 unknown_status NCT01431326
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Not Available Not Available completed NCT06409026
Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension other 4 recruiting NCT00544726
Rehabilitation for Patients With Pulmonary Arterial Hypertension No drug interventions treatment Not Available unknown_status NCT03282266
Safety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension No drug interventions treatment Not Available completed NCT00995566
A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin Not Available Not Available terminated NCT05764265
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants No drug interventions treatment 2 terminated NCT03888365
Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH Not Available Not Available completed NCT03556020
Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH treatment 2 terminated NCT01712620
Spironolactone for Pulmonary Arterial Hypertension treatment 2 recruiting NCT01557582
Assessmet of Patients With PAH Right Ventricular Volume No drug interventions Not Available Not Available completed NCT01934582
A Pharmacokinetic Substudy of the TDE-PH-304 Protocol other 3 completed NCT04435782
A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging treatment 4 terminated NCT02558231
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension treatment 3 completed NCT01484431
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension treatment 1 / 2 completed NCT01799473
Tyvaso Dosing and Titration Evaluation: TyTRATE Registry No drug interventions Not Available Not Available completed NCT05417373
Algorithms to Diagnose Pulmonary Arterial Hypertension No drug interventions Not Available Not Available unknown_status NCT01321073
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study No drug interventions supportive_care Not Available active_not_recruiting NCT00963027
Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil treatment 1 completed NCT01043627
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) No drug interventions Not Available Not Available completed NCT03401476
Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension treatment 2 unknown_status NCT05439460
Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension treatment 4 completed NCT02847260
Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID) treatment 4 completed NCT04991194
Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058 treatment 1 terminated NCT02858791
MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT01105091
Epoprostenol for Injection in Pulmonary Arterial Hypertension treatment 4 completed NCT04450862
Anxiety Self-management Intervention for Pulmonary Hypertension No drug interventions other Not Available unknown_status NCT01841762
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument treatment 3 completed NCT01835080
Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH) No drug interventions Not Available Not Available terminated NCT01508780
Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan No drug interventions Not Available 4 withdrawn NCT03718780
Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise No drug interventions other Not Available unknown_status NCT01355380
Efficacy of Ventavis Used in Real-life Setting. Not Available Not Available completed NCT05242380
Exercise Training in Patients With Pulmonary Arterial Hypertension No drug interventions treatment Not Available completed NCT03476629
Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension. No drug interventions treatment Not Available unknown_status NCT00433329
Combination Therapy in Pulmonary Arterial Hypertension No drug interventions treatment 4 completed NCT03045029
ADAPT - A Patient Registry of the Real-world Use of Orenitram® Not Available Not Available active_not_recruiting NCT03550729
Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary Hypertension No drug interventions basic_science Not Available active_not_recruiting NCT04930289
Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs No drug interventions Not Available Not Available enrolling_by_invitation NCT05452889
PET Image in PAH Patients No drug interventions diagnostic 0 recruiting NCT01623492
Eisenmenger Quality Enhancement Research Initiative No drug interventions Not Available Not Available completed NCT04811092
Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) No drug interventions treatment 3 recruiting NCT01470144
Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT05948644
The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension No drug interventions treatment 1 completed NCT03841344
Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH No drug interventions diagnostic Not Available unknown_status NCT01302444
Treprostinil Combined With Tadalafil for Pulmonary Hypertension No drug interventions treatment 4 terminated NCT01094067
Tezosentan in Patients With Pulmonary Arterial Hypertension No drug interventions supportive_care 2 terminated NCT00319267
Bosentan in Children With Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT06196801
Efficacy of Triple-Combination Therapy in Severe PAH-CHD No drug interventions Not Available Not Available recruiting NCT01743001
Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome No drug interventions treatment 3 completed NCT03251872
Olaparib for PAH: a Pilot Study No drug interventions treatment 0 terminated NCT02310672
REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension No drug interventions treatment 4 completed NCT03567668
Surgical Valvuloplasty for Congenital Mitral Insufficiency No drug interventions Not Available Not Available unknown_status NCT02207868
3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH No drug interventions Not Available Not Available unknown_status NCT03016468
Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH No drug interventions treatment 2 withdrawn NCT00625469
Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan No drug interventions treatment 4 withdrawn NCT01357746
Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler) No drug interventions diagnostic 1 terminated NCT05938946
Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults No drug interventions treatment 1 recruiting NCT05587712
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008) No drug interventions treatment 2 recruiting NCT02436512
Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide No drug interventions diagnostic 3 withdrawn NCT00806312
The Expression and Significance of MiRNA No drug interventions Not Available Not Available completed NCT02885012
Crossover Study From Macitentan or Bosentan Over to Ambrisentan No drug interventions treatment 4 terminated NCT01397110
Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects No drug interventions supportive_care Not Available recruiting NCT00796510
Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety No drug interventions treatment 3 terminated NCT01457781
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 2 completed NCT05464095
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study No drug interventions treatment Not Available recruiting NCT03049995
Stress Echo 2020 - The International Stress Echo Study No drug interventions Not Available Not Available unknown_status NCT02893995
Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension No drug interventions treatment 4 withdrawn NCT03657095
A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension No drug interventions treatment 3 terminated NCT05622695
Non-invasive Pulmonary Artery Prediction No drug interventions Not Available Not Available recruiting NCT01907295
National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension No drug interventions Not Available Not Available unknown_status NCT01106014
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT04791514
A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 2 terminated NCT00453414
Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension No drug interventions treatment 2 withdrawn NCT01847014
Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument No drug interventions treatment 3 terminated NCT00990314
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients No drug interventions treatment 2 completed NCT01451255
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging No drug interventions Not Available Not Available completed NCT04991155
Effect of Food on BIA 5-1058 No drug interventions treatment 1 completed NCT04451850
HRV as a Marker of Treatment Response in PAH Arterial Hypertension No drug interventions Not Available Not Available recruiting NCT02835950
TReatment Of Pulmonary HYpertension 1-US Study No drug interventions treatment Not Available active_not_recruiting NCT00667823
Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT00926523
Biomarkers in the Evaluation of Chronic Lung Disease No drug interventions Not Available Not Available completed NCT02249923
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry No drug interventions Not Available Not Available recruiting NCT02961023
The Effect of Adding Exercise Training to Optimal Therapy in PAH No drug interventions treatment Not Available completed NCT04280523
TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH No drug interventions basic_science 2 completed NCT03638908
Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial No drug interventions treatment 2 completed NCT04677608
Pulmonary Hypertension Modality of Death and Validation of REVEAL Risk Score No drug interventions Not Available Not Available unknown_status NCT00942708
Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension No drug interventions treatment 2 completed NCT01330108
Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension No drug interventions treatment 4 completed NCT00993408
Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH) No drug interventions other 2 completed NCT01582438
An Open Label Access Study For Subjects Who Completed A1481156 No drug interventions Not Available Not Available no_longer_available NCT03810443
Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial Hypertension No drug interventions diagnostic Not Available unknown_status NCT01461343
Evaluation of Pulmonary Perfusion Heterogeneity and Compliance in Patients With Pulmonary Hypertension Using Positron Emission Tomography Imaging No drug interventions other Not Available completed NCT02126943
OPsumit USers Registry No drug interventions Not Available Not Available completed NCT03789643
Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension No drug interventions treatment 2 withdrawn NCT00902603
Ventavis® Registry Protocol No drug interventions Not Available Not Available terminated NCT02081690
A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain No drug interventions treatment 3 terminated NCT04955990
A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants No drug interventions other 4 terminated NCT01721564
Bosentan and Pulmonary Endothelial Function No drug interventions treatment Not Available completed NCT03464864
Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers No drug interventions other 1 completed NCT04732221
A Study of the Efficacy and Safety of MK-5475 in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007) No drug interventions treatment 2 / 3 completed NCT01553721
Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH) No drug interventions treatment 2 completed NCT03055221
TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 4 completed NCT03528902
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension No drug interventions treatment 2 completed NCT01966302
Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 2 completed NCT03278002
A Registry for Patients Taking Uptravi No drug interventions Not Available Not Available completed NCT04744584
Medication Reconciliation in Pulmonary Hypertension No drug interventions Not Available Not Available completed NCT01181284
Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA) No drug interventions Not Available Not Available completed NCT02799979
3D Imaging: Prognostic Role in Pulmonary Arterial Hypertension No drug interventions Not Available Not Available unknown_status NCT00660179
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT03933579
The PAH Platform for Deep Phenotyping in Korean Subjects No drug interventions Not Available Not Available unknown_status NCT05861479
Prognostic Value of Estimated Plasma Volume in Pulmonary Hypertension No drug interventions Not Available Not Available completed NCT00625079
Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil No drug interventions treatment 4 withdrawn NCT06567379
Myocardial Work Evaluation in Patients With PAH No drug interventions Not Available Not Available recruiting NCT02980887
Pulmonary Vascular Disease Phenomics Program PVDOMICS No drug interventions Not Available Not Available active_not_recruiting NCT02060487
Effects of Oral Sildenafil on Mortality in Adults With PAH No drug interventions treatment 4 terminated NCT02080533
Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension No drug interventions treatment 1 / 2 completed NCT02899533
[18F]FES PET/CT in PAH No drug interventions Not Available Not Available terminated NCT04503733
A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension No drug interventions treatment 1 unknown_status NCT03924154
A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1) No drug interventions treatment 2 terminated NCT01260454
The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain No drug interventions treatment 2 completed NCT04691154
A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD No drug interventions treatment 3 recruiting NCT00722254
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder No drug interventions Not Available Not Available terminated NCT01028651
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension No drug interventions Not Available Not Available completed NCT01268553
Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication No drug interventions treatment 4 completed NCT03819777
Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH) No drug interventions Not Available Not Available unknown_status NCT01557647
Safety and Efficacy of Inhaled Treprostinil in Patients With PAH No drug interventions treatment 3 withdrawn NCT06543745
Safety and Impact of Low Resistance Exercise Training on Quality of Life in Pulmonary Arterial Hypertension No drug interventions other Not Available not_yet_recruiting NCT06351345
129 Xenon Imaging in Patients Treated With Sotatercept No drug interventions diagnostic 2 not_yet_recruiting NCT04125745
Oral CXA-10 in Pulmonary Arterial Hypertension No drug interventions treatment 2 terminated NCT01066845
Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT01468545
Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System No drug interventions Not Available Not Available completed NCT01131845
The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil No drug interventions treatment 1 completed NCT04787445
Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT03688698
PET/MRI in PAH Patients No drug interventions Not Available Not Available completed NCT00709098
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT01600898
Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers No drug interventions Not Available Not Available completed NCT05975905
A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study). No drug interventions treatment 2 recruiting NCT01054105
Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT01588405
Remodulin® to Oral Treprostinil Transition No drug interventions treatment 2 completed NCT00323297
Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension No drug interventions treatment 4 completed NCT04241497
Home-based Exercise Training in Patients With Pulmonary Arterial Hypertension: Effect on Skeletal Muscular Function and Metabolism No drug interventions treatment Not Available unknown_status NCT01712997
Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients No drug interventions treatment 3 unknown_status NCT01383083
Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease No drug interventions Not Available Not Available unknown_status NCT02471183
Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT03905083
miRNA and Myokines in Patients With PAH No drug interventions basic_science Not Available withdrawn NCT00866983
Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil No drug interventions Not Available Not Available no_longer_available NCT04555161
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System No drug interventions treatment Not Available recruiting NCT05745961
Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH) No drug interventions Not Available Not Available recruiting NCT03422328
A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies. No drug interventions treatment 3 completed NCT03977428
Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study No drug interventions Not Available Not Available unknown_status NCT04570228
TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study No drug interventions treatment Not Available not_yet_recruiting NCT06312111
Physical Activity and Various Aspects of Quality of Life in Patients With Pulmonary Arterial Hypertension (Ph-PAH) No drug interventions treatment Not Available completed NCT01659411
Adult Congenital Heart Disease Registry (QuERI) No drug interventions Not Available Not Available completed NCT05185011
Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function No drug interventions treatment 1 completed NCT02507011
Beta-blockers in Pulmonary Arterial Hypertension No drug interventions treatment 2 terminated NCT05618093
Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH No drug interventions diagnostic Not Available enrolling_by_invitation NCT03926793
Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension No drug interventions treatment 1 completed NCT02799771
HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION No drug interventions Not Available Not Available completed NCT04884971
Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study No drug interventions treatment 1 completed NCT00792571
An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients No drug interventions treatment 2 completed NCT01265888
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. No drug interventions treatment 2 completed NCT04576988
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR) No drug interventions treatment 3 completed NCT04991207
Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan No drug interventions treatment 1 completed NCT03315507
A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH No drug interventions treatment 1 completed NCT00832507
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 2 terminated NCT01926509
Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005) No drug interventions treatment 1 completed NCT04528056
Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension No drug interventions treatment 1 / 2 unknown_status NCT00709956
Iloprost Power 15 in Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT02000856
BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension No drug interventions treatment Not Available completed NCT01725256
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 2 terminated NCT05665556
REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE) No drug interventions Not Available Not Available recruiting NCT06009185
Safety and Efficacy of BIA 5-1058 in PAH No drug interventions treatment 2 completed NCT00781885
A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients No drug interventions treatment 2 completed NCT01959815
Novel Screening Strategies for Scleroderma PAH No drug interventions Not Available Not Available completed NCT05060315
Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin No drug interventions Not Available Not Available active_not_recruiting NCT05124015
Exercise Capacity Respiratory Muscle Strength Dyspnea and Physical Activity in Pediatric Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT04483115
Acute Haemodynamic Study of TPN171H in Patients With Pulmonary Arterial Hypertension No drug interventions treatment 2 completed NCT04086537
BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT01179737
Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 2 terminated NCT05343637
A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension No drug interventions treatment 2 completed NCT05564637
A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension No drug interventions treatment 2 enrolling_by_invitation NCT06072937
IntelliStent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy No drug interventions treatment Not Available not_yet_recruiting NCT02746237
Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585 No drug interventions treatment 1 completed NCT06549452
Mobile Health Intervention to Improve Exercise in Pediatric PH No drug interventions treatment Not Available not_yet_recruiting NCT01739400
Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome No drug interventions treatment 3 terminated NCT01092559
Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide No drug interventions diagnostic 2 completed NCT01827059
Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE No drug interventions treatment 2 unknown_status NCT05641675
Non-invasive Pulmonary Artery Prediction (ADOPTS) No drug interventions Not Available Not Available not_yet_recruiting NCT01637675
Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension No drug interventions treatment 2 / 3 unknown_status NCT00621075
Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans No drug interventions Not Available Not Available completed NCT00367770
BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology No drug interventions treatment 4 completed NCT02036970
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT No drug interventions treatment 2 completed NCT01457170
Effects of Apelin on the Lung Circulation in Pulmonary Hypertension No drug interventions basic_science Not Available unknown_status NCT06137742
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension No drug interventions basic_science 1 recruiting NCT02939599
Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients No drug interventions treatment 2 terminated NCT01908699
Beraprost-314d Added-on to Tyvaso® (BEAT) No drug interventions treatment 3 completed NCT02028299
Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography No drug interventions diagnostic Not Available completed NCT02583906
Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment No drug interventions treatment Not Available terminated NCT01112306
ACT-293987 in Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT02736149
Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) No drug interventions treatment 2 terminated NCT01458236
A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor No drug interventions treatment 3 withdrawn NCT02032836
Comparative PK PD Study in PAH Patients (Fox vs. I-Neb) No drug interventions treatment 1 / 2 completed NCT01545336
Anastrozole in Patients With Pulmonary Arterial Hypertension No drug interventions treatment 2 completed NCT01100736
Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3) No drug interventions basic_science 0 completed NCT00811018
A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension No drug interventions Not Available 3 terminated NCT03236818
Goal Oriented Strategy to Preserve Ejection Fraction Trial No drug interventions treatment 4 unknown_status NCT06176118
Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension No drug interventions treatment 2 not_yet_recruiting NCT02391441
Ventricular Reversed Remodeling After LTX in PAH Patients No drug interventions Not Available Not Available completed NCT04076241
Effects of Adding Yoga Respiratory Training to Osteopathic Manipulative Treatment in Pulmonary Arterial Hypertension No drug interventions treatment Not Available completed NCT01105117
Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401 No drug interventions treatment 4 completed NCT05437224
Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT01847716
Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension No drug interventions Not Available Not Available terminated NCT01431716
Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT03069716
A Mobile Health Intervention in Pulmonary Arterial Hypertension No drug interventions treatment Not Available completed NCT06180096
Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablets No drug interventions other 1 completed NCT01172496
A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers No drug interventions treatment 1 completed NCT04808596
Pulmonary Hypertension Biorepository and Registry No drug interventions Not Available Not Available recruiting NCT02664558
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) No drug interventions treatment 2 completed NCT05036135
A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 2 / 3 terminated NCT02763735
Right Ventricular Metabolism in Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT01251835
Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan No drug interventions basic_science 1 withdrawn NCT01864863
To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers No drug interventions treatment 1 completed NCT05660863
A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets No drug interventions treatment 1 not_yet_recruiting NCT03051763
The Effects of Commercial Air Travel on Patients Suffering From Pulmonary Hypertension No drug interventions Not Available Not Available unknown_status NCT02318186
Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH) No drug interventions Not Available Not Available completed NCT03950739
Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso No drug interventions treatment 1 completed NCT00795639
Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS) No drug interventions treatment 3 terminated NCT02516722
TReatment Of Pulmonary HYpertension 1 Study No drug interventions treatment Not Available unknown_status NCT01792622
Patient Reported Outcomes in Pulmonary Arterial Hypertension No drug interventions Not Available Not Available withdrawn NCT03554330
Combined Use of Radiofrequency-ablation and Balloon-septostomy in the Creation of a Stable Inter-atrial Communication No drug interventions treatment Not Available recruiting NCT04903730
Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution No drug interventions basic_science 1 completed NCT00423748
Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension. No drug interventions treatment 3 completed NCT01446848
Oral Iron Supplementation in Pulmonary Hypertension No drug interventions treatment Not Available completed NCT05649748
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 2 / 3 recruiting NCT03959748
DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL No drug interventions Not Available Not Available recruiting NCT01251848
Drug Interaction Between Ritonavir And Sitaxsentan No drug interventions basic_science 1 withdrawn NCT04041648
Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606 other 1 completed NCT01352026
Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH) No drug interventions Not Available 2 withdrawn NCT02525926
Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension No drug interventions treatment Not Available terminated NCT02882126
An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension No drug interventions treatment 4 withdrawn NCT02927366
Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients No drug interventions treatment 2 terminated NCT01880866
(-)-Epicatechin and Pulmonary Arterial Hypertension No drug interventions treatment 1 withdrawn NCT00796666
Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil No drug interventions treatment 3 terminated NCT03045666
Impact of Rehabilitation Program on PAH Patients Treated With Macitentan. No drug interventions supportive_care Not Available unknown_status NCT04090866
Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study No drug interventions Not Available Not Available terminated NCT04062565
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH treatment 3 unknown_status NCT03884465
Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil No drug interventions treatment 2 terminated NCT01266265
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies No drug interventions Not Available Not Available completed NCT00159874
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children treatment 3 completed NCT00902174
Imatinib (QTI571) in Pulmonary Arterial Hypertension No drug interventions treatment 3 completed NCT00319020
Bosentan in Children With Pulmonary Arterial Hypertension Extension Study No drug interventions treatment 3 completed NCT01244620
A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses No drug interventions treatment 1 terminated NCT03683082
Oxygen Treatment and Pulmonary Arterial Hypertension No drug interventions treatment Not Available unknown_status NCT00706082
Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) No drug interventions Not Available Not Available terminated NCT05224531
Effect of CS1 in Subjects With Pulmonary Arterial Hypertension No drug interventions treatment 2 recruiting NCT00435331
6R-BH4 Pulmonary Arterial Hypertension Study No drug interventions treatment 1 completed NCT06445673
A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients No drug interventions Not Available Not Available enrolling_by_invitation NCT01445873
Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH) No drug interventions Not Available Not Available completed NCT06484673
Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets No drug interventions other 1 completed NCT01174173
Ranolazine and Pulmonary Hypertension No drug interventions treatment 3 completed NCT04071327
Pulmonary Hypertension Association Registry No drug interventions Not Available Not Available recruiting NCT01615627
Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain No drug interventions treatment 4 withdrawn NCT01165476
Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities No drug interventions treatment 1 completed NCT04994860
Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil No drug interventions treatment 1 completed NCT01557660
Inhaled Treprostinil for PAH: Open-label Extension No drug interventions treatment 3 withdrawn NCT02279160
Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension No drug interventions treatment 2 completed NCT02253394
The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study No drug interventions treatment 4 terminated NCT05343091
Prognostic Value of the Right Ventricular Function by Portable Ultrasound in Patients With Pulmonary Hypertension. No drug interventions Not Available Not Available unknown_status NCT03554291
Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension No drug interventions treatment 2 completed NCT05427162
A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist No drug interventions treatment 1 completed NCT06053580
Repurposing Valsartan May Protect Against Pulmonary Hypertension No drug interventions treatment 2 recruiting NCT00058929
A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension treatment 4 completed NCT02652429
Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH No drug interventions treatment 3 unknown_status NCT01905189
Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension No drug interventions treatment Not Available unknown_status NCT04254289
Pilot Randomized Trial of Ambulatory Exercise in Pulmonary Hypertension No drug interventions supportive_care Not Available withdrawn NCT01607489
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography No drug interventions diagnostic Not Available completed NCT03497689
EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension No drug interventions treatment 4 completed NCT02691689
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions No drug interventions diagnostic Not Available recruiting NCT01208792
Auto-immunity and Pulmonary Arterial Hypertension No drug interventions diagnostic Not Available completed NCT04675944
Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil No drug interventions treatment 1 completed NCT02911844
Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension No drug interventions treatment 2 completed NCT03364244
Revatio Special Investigation for Long-term Use in Pediatric Patients No drug interventions Not Available Not Available completed NCT01897740
Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil No drug interventions Not Available Not Available no_longer_available NCT05368467
National Registry and Cohort Study of Pulmonary Vascular Disease No drug interventions Not Available Not Available recruiting NCT06274801
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) No drug interventions treatment 3 not_yet_recruiting NCT00963001
Effect of Food on the Pharmacokinetics of Oral Treprostinil No drug interventions treatment 1 completed NCT06554301
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension No drug interventions treatment 1 not_yet_recruiting NCT02968901
Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA) No drug interventions treatment 4 terminated NCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) Not Available Not Available recruiting NCT03655704
Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study No drug interventions screening 0 completed NCT04816604
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 2 recruiting NCT01391104
Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension No drug interventions treatment Not Available completed NCT01829672
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography No drug interventions diagnostic Not Available completed NCT02725372
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH No drug interventions treatment 3 terminated NCT01392469
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants No drug interventions treatment 3 completed NCT04712669
A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2) No drug interventions treatment 2 completed NCT01725269
Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05 No drug interventions treatment 2 terminated NCT00477269
Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension No drug interventions treatment 2 / 3 completed NCT00439946
Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH No drug interventions treatment 4 terminated NCT03708146
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058 No drug interventions treatment 1 completed NCT04778046
Pulmonary Hypertension SOLAR No drug interventions diagnostic 2 recruiting NCT02932410
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 3 active_not_recruiting NCT04968210
Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH) No drug interventions Not Available Not Available recruiting NCT05203510
A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension No drug interventions treatment 4 recruiting NCT05655481
Telerehabilitation Program Via Videoconference PAH - Randomized Clinical Trial No drug interventions treatment Not Available not_yet_recruiting NCT03602781
Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric No drug interventions treatment 3 withdrawn NCT04991181
Absorption, Distribution, Metabolism and Excretion of BIA 5-1058 No drug interventions treatment 1 completed NCT01392495
Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 3 terminated NCT05208814
a Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy Subjects No drug interventions treatment 1 completed NCT02885155
Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT05569655
Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH No drug interventions treatment Not Available unknown_status NCT01548950
Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension No drug interventions treatment Not Available completed NCT05318950
A nUtrition and Lifestyle Intervention in Patients With Pulmonary Arterial HypertensIon No drug interventions treatment Not Available completed NCT02023450
Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension No drug interventions treatment 0 unknown_status NCT03738150
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension No drug interventions treatment 2 completed NCT04416750
Positioning Imatinib for Pulmonary Arterial Hypertension No drug interventions treatment 2 active_not_recruiting NCT00403650
Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension No drug interventions treatment 4 completed NCT02891850
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy No drug interventions treatment 4 completed NCT01795950
Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH) No drug interventions treatment 1 terminated NCT03833323
Implantable System for Remodulin Post-Approval Study No drug interventions Not Available Not Available withdrawn NCT00566423
Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH) No drug interventions diagnostic Not Available completed NCT01757808
A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension No drug interventions treatment 1 completed NCT04896008
A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH) No drug interventions treatment 3 active_not_recruiting NCT06454838
Exercise Capacity Muscle Oxygenation and Arterial Stiffness in Children With Pulmonary Arterial Hypertension No drug interventions Not Available Not Available recruiting NCT01417338
Registry for Pulmonary Hypertension in China No drug interventions Not Available Not Available unknown_status NCT04130243
Biomarkers in Pediatric Congenital Heart Disease and PAH No drug interventions Not Available Not Available active_not_recruiting NCT01953965
Look at Way the Heart Functions in People With Pulmonary Hypertension (PH) Who Have Near Normal Right Ventricle (RV) Function and People With Pulmonary Hypertension Who Have Impaired RV Function. Using Imaging Studies PET Scan and Cardiac MRI. diagnostic 2 terminated NCT01247805
A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions No drug interventions treatment 1 completed NCT05731492
A Study of Macitentan in Children Below 2 Years of Age No drug interventions basic_science 1 withdrawn NCT05996302
HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level) No drug interventions supportive_care Not Available active_not_recruiting NCT06429579
Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension No drug interventions treatment Not Available recruiting NCT04456998
GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) treatment 2 completed NCT00502398
Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension? No drug interventions Not Available Not Available unknown_status NCT06035861
Endothelial Cell Activation and Total Pulmonary Resistance in PAH basic_science Not Available not_yet_recruiting NCT04610788
Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH No drug interventions Not Available Not Available recruiting NCT05056532
Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension No drug interventions Not Available Not Available completed NCT04194632
Right Ventricular Pacing in Pulmonary Arterial Hypertension No drug interventions treatment Not Available unknown_status NCT06122922
Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN) No drug interventions diagnostic 2 withdrawn NCT06544148
Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study No drug interventions Not Available Not Available not_yet_recruiting NCT06003244
High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT) No drug interventions other Not Available active_not_recruiting NCT03198910
Retrospective Data Analysis of Data From the Zurich PH Registry No drug interventions Not Available Not Available completed NCT03195543
Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension No drug interventions Not Available Not Available unknown_status NCT03189602
Pulmonary Artery Involvement in Takayasu's Arteritis No drug interventions Not Available Not Available completed NCT04337671
Impact of Aerobic Training on Sleep Quality and Aerobic Fitness in Male Patients With Pulmonary Artery Hypertension No drug interventions supportive_care Not Available completed NCT06084559
HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT) No drug interventions other Not Available active_not_recruiting NCT05421949
Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAH No drug interventions Not Available Not Available completed NCT06072417
HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level) No drug interventions supportive_care Not Available active_not_recruiting NCT03617458
Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension No drug interventions treatment 2 active_not_recruiting NCT03138863
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO) No drug interventions treatment Not Available recruiting NCT01581086
Vascular Subphenotypes of Lung Disease in HIV & COPD No drug interventions Not Available Not Available completed NCT02684786
A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension No drug interventions treatment 1 withdrawn NCT02966665
: Vascular Function in Health and Disease No drug interventions basic_science 1 recruiting NCT03979482
Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH No drug interventions Not Available Not Available completed NCT03152773
Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires No drug interventions diagnostic Not Available recruiting NCT04094272
Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection No drug interventions Not Available Not Available completed NCT02102672
Trimetazidine in Pulmonary Artery Hypertension No drug interventions treatment 2 unknown_status NCT01763112
Training With Whole Body Vibration Device in Patients With PAH No drug interventions treatment Not Available unknown_status NCT06258850
REstoration of VItamin D in Pulmonary Arterial Hypertension No drug interventions treatment 4 not_yet_recruiting NCT05339152
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia No drug interventions treatment Not Available not_yet_recruiting